LONDON, Dec 14 (Reuters) - A clinical trial of the widely-used antibiotic azithromycin in COVID-19 patients in hospital has found no convincing evidence of benefit, prompting doctors to announce on ...
Azithromycin, an antibiotic used to treat COVID-19, was no more effective at freeing non-hospitalized patients of COVID-19 symptoms than a placebo, a study found. Findings from researchers affiliated ...
Early on in the ongoing coronavirus disease 2019 (COVID-19) pandemic, the antibiotic azithromycin was regarded as being a potentially highly effective drug against the virus that causes it, severe ...
Azithromycin has been suggested as a possible COVID treatment, but clinicians should be aware of the drug’s potential to cause heart problems when taken with commonly used medications, researchers ...
In the midst of a pandemic, lots of people have ideas for cures. We are desperate for therapies and the virus can be deadly. The problem is that the presumptive cure can add danger to the disease, ...
Azithromycin -- a commonly-prescribed antibiotic -- also is being investigated as a potential treatment for COVID-19. Researchers have found that azithromycin by itself is not associated with an ...
Ongoing coverage of COVID-19, and its impact on Seattle and the technology industry. See all of GeekWire’s special coverage. by Alan Boyle on May 14, 2020 at 7:54 pm June 20, 2020 at 1:31 pm ...
The National Institutes of Health on Tuesday recommended against using hydroxychloroquine and azithromycin, a drug combination touted by President Trump, together to treat the novel coronavirus, ...
Debates over whether hydroxychloroquine should be taken to help lessen the duration and impact of COVID-19 have revolved around the drug's reputation for causing cardiac events such as abnormal heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback